THYROID CANCER

Lights on HBME-1: the elusive biomarker in thyroid cancer pathology
Giorgio Cazzaniga, Davide Seminati, Andrew Smith, Isabella Piga, Giulia Capitoli, Mattia Garancini, Vincenzo L'Imperio, Nicola Fusco, Fabio Pagni

Journal of Clinical Pathology Sep 2022, 75 (9) 588-592; DOI: 10.1136/jclinpath-2022-208248
Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier
Sergei Titov, Pavel S Demenkov, Sergei A Lukyanov, Sergei V Sergiyko, Gevork A Katanyan, Yulia A Veryaskina, Mikhail K Ivanov

Journal of Clinical Pathology Nov 2020, 73 (11) 722-727; DOI: 10.1136/jclinpath-2020-206445
A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy
T Hakala, I Kholová, J Sand, R Saaristo, P Kellokumpu-Lehtinen

Journal of Clinical Pathology Dec 2013, 66 (12) 1046-1050; DOI: 10.1136/jclinpath-2013-201559
Single thyroid tumour showing multiple differentiated morphological patterns and intramorphological molecular genetic heterogeneity
Heather K Schopper, Aaron Stence, Deqin Ma, Nitin A Pagedar, Robert A Robinson

Journal of Clinical Pathology Feb 2017, 70 (2) 116-119; DOI: 10.1136/jclinpath-2016-203821
Intermediate microRNA expression profile in Graves’ disease falls between that of normal thyroid tissue and papillary thyroid carcinoma
Matthias Pohl, Florian Grabellus, Karl Worm, Georg Arnold, Martin Walz, Kurt Werner Schmid, Sien-Yi Sheu-Grabellus

Journal of Clinical Pathology Jan 2017, 70 (1) 33-39; DOI: 10.1136/jclinpath-2016-203739
Subcategorisation of AUS/FLUS thyroid lesions as per the 2017 Bethesda System for Reporting Thyroid Cytopathology: a retrospective study from a tertiary care centre analysing risk of malignancy (ROM) of the different subcategories
Prerna Guleria, Shipra Agarwal, Venkateswaran K Iyer, Deepali Jain, Sandeep R Mathur, Diksha Yadav

Journal of Clinical Pathology Nov 2019, 72 (11) 771-777; DOI: 10.1136/jclinpath-2019-205985
Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears
Gila Lithwick-Yanai, Nir Dromi, Alexander Shtabsky, Sara Morgenstern, Yulia Strenov, Meora Feinmesser, Vladimir Kravtsov, Marino E Leon, Marián Hajdúch, Syed Z Ali, Christopher J VandenBussche, Xinmin Zhang, Leonor Leider-Trejo, Asia Zubkov, Sergey Vorobyov, Michal Kushnir, Yaron Goren, Sarit Tabak, Etti Kadosh, Hila Benjamin, Temima Schnitzer-Perlman, Hagai Marmor, Maria Motin, Danit Lebanony, Sharon Kredo-Russo, Heather Mitchell, Melissa Noller, Alexis Smith, Olivia Dattner, Karin Ashkenazi, Mats Sanden, Kenneth A Berlin, Dganit Bar, Eti Meiri

Journal of Clinical Pathology Jun 2017, 70 (6) 500-507; DOI: 10.1136/jclinpath-2016-204089
Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome
Ji Yun Yun, Young A Kim, Ji-Young Choe, Hyesook Min, Kyu Sang Lee, Youngho Jung, Sohee Oh, Ji Eun Kim

Journal of Clinical Pathology Feb 2014, 67 (2) 125-133; DOI: 10.1136/jclinpath-2013-201711
Aggressive variants of follicular cell derived thyroid carcinoma; the so called ‘Real Thyroid Carcinomas’
Zubair Baloch, Virginia A LiVolsi, Rashmi Tondon

Journal of Clinical Pathology Sep 2013, 66 (9) 733-743; DOI: 10.1136/jclinpath-2013-201626
Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study
Jun Cao, Jin-Lin Hu, Can Chen, Qing-Liang Wang, Xian-Hua Fang, Yan Zhang, Ming-Hua Ge

Journal of Clinical Pathology Oct 2016, 69 (10) 872-877; DOI: 10.1136/jclinpath-2015-203547

Main menu

THYROID CANCER

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

THYROID CANCER

Pages